Hong Kong drives trials for breast cancer, eye treatments across Greater Bay Area
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
4/15
5-Axis Cultural Radar
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health Hope Pharma founder Dr Dennis Lam Shun-chiu signed a memorandum of understanding with the Greater
